𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P069 Minimal residual disease in acute childhood leukemia

✍ Scribed by J. Buslig; M. Balogh; E. Bardi; C. Kiss; E. Olah; B. Scholtz

Book ID
104323121
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
62 KB
Volume
21
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Monitoring of minimal residual disease i
Monitoring of minimal residual disease in acute myeloid leukemia
✍ Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 587 KB

## Abstract Two highly sensitive methods, multiparameter flow cytometry (MFC) and real‐time quantitative PCR (RQ‐PCR), are increasingly used to monitor minimal residual disease (MRD) and to guide risk‐adapted management in acute myeloid leukemia (AML). An independent prognostic impact has been demo

Copy number alterations in childhood acu
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease
✍ Doris Steinemann; Gunnar Cario; Martin Stanulla; Leonid Karawajew; Marcel Tausch πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 287 KB

## Abstract In vivo response to initial therapy, as assessed by determination of minimal residual disease (MRD) after 5 and 12 weeks of treatment, has evolved as a strong prognostic factor in children with acute lymphoblastic leukemia (ALL) treated according to the BFM regime. Individual treatment